LitAlert ~~ GeneLit.com

    • A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk.
    • Yu Y, Chang K, Chen JS, Bohlender RJ, Fowler J, Zhang D, Huang M, Chang P, Li Y, Wong J, Wang H, Gu J, Wu X, Schildkraut J, Cannon-Albright L, Ye Y, Zhao H, Hildebrandt MAT, Permuth JB, Li D, Scheet P, Huff CD.
    • HGG Adv. 2021 Dec 10 [eCollection 2022 Jan 13];3(1):100078. doi: 10.1016/j.xhgg.2021.100078.
    • Prediction of breast cancer risk based on flow variant analysis of circulating peripheral blood mononuclear cells.
    • Loke J, Alim I, Yam S, Klugman S, Xia LC, Gruber D, Tegay D, LaBella A, Onel K, Ostrer H.
    • HGG Adv. 2022 Jan 7;100085. doi: 10.1016/j.xhgg.2022.100085. Epub ahead of print.
    • Clinical validation of genomic functional screen data: analysis of observed BRCA1 variants in an unselected population cohort.
    • Schiabor Barrett KM, Masnick M, Hatchell KE, Savatt JM, Banet N, Buchanan A, Willard HF.
    • HGG Adv. 2022 Jan 7;100086. doi: 10.1016/j.xhgg.2022.100086.
    • Clinical validation of genomic functional screen data: analysis of observed BRCA1 variants in an unselected population cohort.
    • Schiabor Barrett KM, Masnick M, Hatchell KE, Savatt JM, Banet N, Buchanan A, Willard HF.
    • HGG Adv. 2022 Jan 7;100086. doi: 10.1016/j.xhgg.2022.100086. Epub ahead of print.
    • Can the Synergic Contribution of Multigenic Variants Explain the Clinical and Cellular Phenotypes of a Neurodevelopmental Disorder?
    • Maia N, Nabais Sá MJ, Oliveira C, Santos F, Soares CA, Prior C, Tkachenko N, Santos R, de Brouwer APM, Jacome A, Porto B, Jorge P.
    • Genes (Basel). 2021 Dec 28;13(1):78. doi: 10.3390/genes13010078.